CIMA, the Clínica Universidad de Navarra, and participating research centers, one of which is the Center for Biomedical Engineering (jointly run by TECNUN, CEIT-IK4 and CUN), displayed their capacities to the international biotech industry
The Center for Biomedical Engineering attended BioSpain 2014, the seventh annual international meeting on biotechnology. This year's edition was held at Galicia Congress & Exhibition Palace in Santiago de Compostela.
BioSpain, which is organized by ASEBIO (Spanish Bioindustry Association), is the largest biotechnology event held at the national level, and it is the sixth largest at the international level. The meeting consisted of a trade exhibition, a partnering event, an investment forum, a job and training forum, plenary sessions, and regular sessions organized around various thematic areas and with speakers from both Spain and abroad.
This year's meeting brought together 2,000 participants and 800 companies and institutions from 40 countries, including Portugal, Spain, France, United Kingdom, Canada, Colombia, Mexico, Russia and India.
A delegation of ten people from the University of Navarra and its related research centers (Center for Nutrition Research, Center for Biomedical Engineering, Center for Applied Medical Research (CIMA), Clínica Universidad de Navarra and the Drug Development Unit) ran an exhibition stand where they displayed their capacities in biotechnology, along with ADItech and its various centers.
The University of Navarra's new Center for Biomedical Engineering (CBE) attended the event in order to display its capacities to the biotech industry and the companies in the sector who might wish to partner with CBE on research projects in the field of biomedical engineering.
According to Gustavo Pego, coordinator of CBE, the congress was enormously fruitful. "During the organized partnering sessions we had the opportunity to establish new relationships with more than 15 companies and institutions from the biotech sector that share our capacities interests and with whom we hope to collaborate in the mid term."